BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25070495)

  • 1. The Willingness to Pay for a Quality Adjusted Life Year: A Review of the Empirical Literature.
    Ryen L; Svensson M
    Health Econ; 2015 Oct; 24(10):1289-1301. PubMed ID: 25070495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for a QALY: theoretical and methodological issues.
    Gyrd-Hansen D
    Pharmacoeconomics; 2005; 23(5):423-32. PubMed ID: 15896094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand.
    Nimdet K; Ngorsuraches S
    BMJ Open; 2015 Oct; 5(10):e008123. PubMed ID: 26438135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
    Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
    PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Contingent Valuation Study for Eliciting a Monetary Value of a Quality-Adjusted Life-Year in the General Greek Population.
    Mavrodi A; Aletras V
    Value Health Reg Issues; 2020 Sep; 22():36-43. PubMed ID: 32731168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating a WTP-based value of a QALY: the 'chained' approach.
    Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
    Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT; Tsevat J; Lave JR; Roberts MS
    Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis.
    Byrne MM; O'malley K; Suarez-Almazor ME
    Med Decis Making; 2005; 25(6):655-66. PubMed ID: 16282216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eliciting the Monetary Value of a Quality-Adjusted Life Year in a Greek Outpatient Department in Times of Economic Austerity.
    Mavrodi A; Aletras V; Spanou A; Niakas D
    Pharmacoecon Open; 2017 Dec; 1(4):291-300. PubMed ID: 29441505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monetary value of health-a practical decision-making framework combining equity considerations and WTP.
    Ribarić E; Velić I; Bobinac A
    Eur J Health Econ; 2024 May; ():. PubMed ID: 38769211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WTP for a QALY and health states: More money for severer health states?
    Shiroiwa T; Igarashi A; Fukuda T; Ikeda S
    Cost Eff Resour Alloc; 2013; 11():22. PubMed ID: 24128004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.
    Kouakou CRC; Poder TG
    Eur J Health Econ; 2022 Mar; 23(2):277-299. PubMed ID: 34417905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to pay for QALY: perspectives and contexts in Japan.
    Igarashi A; Goto R; Yoneyama-Hirozane M
    J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
    [No Abstract]   [Full Text] [Related]  

  • 17. Empirical Monetary Valuation of a Quality-Adjusted Life-Year in the Kingdom of Saudi Arabia: A Willingness-to-Pay Analysis.
    Bazarbashi S; De Vol EB; Maraiki F; Al-Jedai A; Ali AA; Alhammad AM; Aljuffali IA; Iskedjian M
    Pharmacoecon Open; 2020 Dec; 4(4):625-633. PubMed ID: 32291726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
    Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
    J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminishing willingness to pay per quality-adjusted life year: valuing acute foodborne illness.
    Haninger K; Hammitt JK
    Risk Anal; 2011 Sep; 31(9):1363-80. PubMed ID: 21488924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-Related Quality of Life and Willingness to Pay per Quality-Adjusted Life-Year Threshold-A Study in Patients with Epilepsy in China.
    Gao L; Xia L; Pan SQ; Xiong T; Li SC
    Value Health Reg Issues; 2015 May; 6():89-97. PubMed ID: 29698200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.